References

References

  1. https://pmc.ncbi.nlm.nih.gov/articles/PMC7973386/
  2. https://pmc.ncbi.nlm.nih.gov/articles/PMC7963035/
  3. https://pmc.ncbi.nlm.nih.gov/articles/PMC5088772/
  4. https://www.nature.com/articles/s41580-020-00313-x
  5. Oral nicotinamide riboside raises NAD+ and lowers biomarkers of neurodegenerative pathology in plasma extracellular vesicles enriched for neuronal origin
  6. https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2022.829658/full
  7. NAD+ in Brain Ageing and Neurodegenerative Disorders
  8. https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.056589
  9. https://cellandbioscience.biomedcentral.com/articles/10.1186/s13578-023-01031-5
  10. https://pmc.ncbi.nlm.nih.gov/articles/PMC4487780/
  11. https://www.nature.com/articles/s41392-020-00311-7
  12. https://academic.oup.com/jes/article/1/7/816/3827720
  13. https://pubmed.ncbi.nlm.nih.gov/37971292/
  14. https://pmc.ncbi.nlm.nih.gov/articles/PMC5384578/
  15. https://pmc.ncbi.nlm.nih.gov/articles/PMC9512238/
  16. https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2020.00246/full
  17. https://www.sciencedirect.com/science/article/pii/S2212877821000351
  18. https://pmc.ncbi.nlm.nih.gov/articles/PMC7442590/
  19. https://pmc.ncbi.nlm.nih.gov/articles/PMC7494058/
  20. https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.056589
  21. https://www.nature.com/articles/s44324-025-00067-0
  22. https://www.mdpi.com/1422-0067/24/3/2959
  23. https://pubmed.ncbi.nlm.nih.gov/37068054/
  24. https://pmc.ncbi.nlm.nih.gov/articles/PMC10692436/
  25. https://pmc.ncbi.nlm.nih.gov/articles/PMC6971268/
  26. https://genomeintegrity.biomedcentral.com/articles/10.1186/2041-9414-4-6
  27. https://www.mdpi.com/2072-6643/13/8/2658
  28. https://pmc.ncbi.nlm.nih.gov/articles/PMC9116917/